4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium
C29H21FNO+ — CID 140828109
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium
4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium (PubChem CID 140828109) has the molecular formula C29H21FNO+ and a molecular weight of 418.49 g/mol. Its IUPAC name is 4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium.
Molecular Properties
| Compound Name | 4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium |
|---|---|
| PubChem CID | 140828109 |
| Molecular Formula | C29H21FNO+ |
| Molecular Weight | 418.49 g/mol |
| Exact Mass | 418.16 |
| IUPAC Name | 4-(4-fluorophenyl)-1-methyl-2-(3-methylnaphtho[2,3-b][1]benzofuran-4-yl)pyridin-1-ium |
| SMILES | Cc1ccc2c(oc3cc4ccccc4cc32)c1-c1cc(-c2ccc(F)cc2)cc[n+]1C |
| InChI | InChI=1S/C29H21FNO/c1-18-7-12-24-25-15-20-5-3-4-6-21(20)17-27(25)32-29(24)28(18)26-16-22(13-14-31(26)2)19-8-10-23(30)11-9-19/h3-17H,1-2H3/q+1 |
| InChIKey | LPFLWDFUZYYKNX-UHFFFAOYSA-N |
| XLogP | 7.35 |
| TPSA | 17.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.49 |
| LogP ≤ 5 | 7.35 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 140828109 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.